Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Vanderbilt University, AstraZeneca partner to identify candidate drugs for major brain diseases

Vanderbilt University, AstraZeneca partner to identify candidate drugs for major brain diseases

Thermo Fisher's expandable portfolio of lab automation solutions to be showcased at SLAS 2013

Thermo Fisher's expandable portfolio of lab automation solutions to be showcased at SLAS 2013

UCSF teams to study new ways to reduce childhood mortality and disease in developing nations

UCSF teams to study new ways to reduce childhood mortality and disease in developing nations

Pfizer, Repligen sign licensing deal to advance spinal muscular atrophy program

Pfizer, Repligen sign licensing deal to advance spinal muscular atrophy program

Kareus announces start of KU-046 Phase I study in Alzheimer's

Kareus announces start of KU-046 Phase I study in Alzheimer's

Vismodegib team wins Drug Discovery of the Year award

Vismodegib team wins Drug Discovery of the Year award

British Pharmacological Society celebrates the start of annual meeting

British Pharmacological Society celebrates the start of annual meeting

Fluidigm, GIS announce establishment of first single-cell genomics research center in Asia

Fluidigm, GIS announce establishment of first single-cell genomics research center in Asia

New way to effectively make designer drugs that hit collections of protein targets simultaneously

New way to effectively make designer drugs that hit collections of protein targets simultaneously

New collaborative model for drug discovery can ensure antibiotics are not lost to resistance

New collaborative model for drug discovery can ensure antibiotics are not lost to resistance

GSK, Fred Hutch to develop therapeutics against facioscapulohumeral muscular dystrophy

GSK, Fred Hutch to develop therapeutics against facioscapulohumeral muscular dystrophy

Acetylon announces results from selective HDAC 1/2 inhibitor preclinical study on SCD and bT

Acetylon announces results from selective HDAC 1/2 inhibitor preclinical study on SCD and bT

Isis, Biogen Idec partner to discover and develop antisense drugs against neuromuscular disorders

Isis, Biogen Idec partner to discover and develop antisense drugs against neuromuscular disorders

New study could help develop anti-inflammatory drugs with fewer side effects

New study could help develop anti-inflammatory drugs with fewer side effects

Bicycle Therapeutics secures £3.75 million equity financing for drug discovery

Bicycle Therapeutics secures £3.75 million equity financing for drug discovery

Scientists identify key molecular pathway that leads to depression

Scientists identify key molecular pathway that leads to depression

USPTO approves patent for Axiogenesis’ in vitro drug discovery assay to treat HCM

USPTO approves patent for Axiogenesis’ in vitro drug discovery assay to treat HCM

Primitive human stem cells resistant to human cytomegalovirus

Primitive human stem cells resistant to human cytomegalovirus

Two Sanford-Burnham projects win International Space Station Research Competition

Two Sanford-Burnham projects win International Space Station Research Competition

Researchers discover alternative mechanism for Ras protein activation

Researchers discover alternative mechanism for Ras protein activation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.